{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:46:04Z","timestamp":1770777964082,"version":"3.50.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12014-019-9246-0","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:04:18Z","timestamp":1560996258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A proteome-wide immuno-mass spectrometric identification of serum autoantibodies"],"prefix":"10.1186","volume":"16","author":[{"given":"Milena","family":"Music","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoninus","family":"Soosaipillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihor","family":"Batruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Prassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-820X","authenticated-orcid":false,"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"9246_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ncprheum0895","volume":"4","author":"K Elkon","year":"2008","unstructured":"Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008;4:491\u20138.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"9246_CR2","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","volume":"125","author":"J Suurmond","year":"2015","unstructured":"Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015;125:2194\u2013202.","journal-title":"J Clin Invest"},{"key":"9246_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2016.01.017","volume":"15","author":"P Zaenker","year":"2016","unstructured":"Zaenker P, Gray ES, Ziman MR. Autoantibody production in cancer\u2014the humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15:477\u201383.","journal-title":"Autoimmun Rev"},{"key":"9246_CR4","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1111\/j.1742-4658.2009.07396.x","volume":"276","author":"HT Tan","year":"2009","unstructured":"Tan HT, Low J, Lim SG, Chung MCM. Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 2009;276:6880\u2013904.","journal-title":"FEBS J"},{"key":"9246_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00001","volume":"9","author":"Duarte J Da Gama","year":"2018","unstructured":"Da Gama Duarte J, Parakh S, Andrews MC, et al. Autoantibodies may predict immune-related toxicity: results from a phase I study of intralesional Bacillus Calmette-Gu\u00e9rin followed by ipilimumab in patients with advanced metastatic melanoma. Front Immunol. 2018;9:1\u20139.","journal-title":"Front Immunol"},{"key":"9246_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12967-018-1452-4","volume":"16","author":"MF Gowen","year":"2018","unstructured":"Gowen MF, Giles KM, Simpson D, et al. Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. J Transl Med. 2018;16:82.","journal-title":"J Transl Med"},{"key":"9246_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1309\/LM2T3OU3RZRTHKSN","volume":"42","author":"JW Pedersen","year":"2011","unstructured":"Pedersen JW, Wandall HH. Autoantibodies as biomarkers in cancer. Lab Med. 2011;42:623\u20138.","journal-title":"Lab Med"},{"key":"9246_CR8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.133.2.969","volume":"133","author":"L Bj\u00f6rck","year":"1984","unstructured":"Bj\u00f6rck L, Kronvall G. Purificiation and some properties of streptoccoal protein G, a novel IgG-binding reagent. J Immunol. 1984;133:969\u201374.","journal-title":"J Immunol"},{"key":"9246_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198\u2013207.","journal-title":"Nature"},{"key":"9246_CR10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.clinbiochem.2017.07.012","volume":"50","author":"S Farkona","year":"2017","unstructured":"Farkona S, Soosaipillai A, Filippou P, et al. Generation of monoclonal antibodies and development of an immunofluorometric assay for the detection of CUZD1 in tissues and biological fluids. Clin Biochem. 2017;50:1168\u201374.","journal-title":"Clin Biochem"},{"key":"9246_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.crohns.2012.10.011","volume":"7","author":"L Komorowski","year":"2013","unstructured":"Komorowski L, Teegen B, Probst C, et al. Autoantibodies against exocrine pancreas in Crohn\u2019s disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohns Colitis. 2013;7:780\u201390.","journal-title":"J Crohns Colitis"},{"key":"9246_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1515\/cclm-2016-1120","volume":"55","author":"S Farkona","year":"2017","unstructured":"Farkona S, Soosaipillai A, Filippou P, et al. Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases. Clin Chem Lab Med. 2017;55:1574\u201381.","journal-title":"Clin Chem Lab Med"},{"key":"9246_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/08916930410001710668","volume":"37","author":"M Hawa","year":"2004","unstructured":"Hawa M, Beyan H, Leslie RDG. Principles of autoantibodies as disease-specific markers. Autoimmunity. 2004;37:253\u20136.","journal-title":"Autoimmunity"},{"key":"9246_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/ITT.S126227","volume":"6","author":"JM Yoest","year":"2017","unstructured":"Yoest JM. Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review. Immunotargets Ther. 2017;6:73\u201382.","journal-title":"Immunotargets Ther"},{"key":"9246_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1373\/clinchem.2010.157776","volume":"57","author":"K Ohyama","year":"2017","unstructured":"Ohyama K, Ueki Y, Kawakami A, et al. Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis. Clin Chem. 2017;57:905\u20139.","journal-title":"Clin Chem"},{"key":"9246_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.4153","volume":"14","author":"DP Zolg","year":"2017","unstructured":"Zolg DP, Wilhelm M, Schnatbaum K, et al. Building ProteomeTools based on a complete synthetic human proteome. Nat Methods. 2017;14:259\u201362.","journal-title":"Nat Methods"},{"key":"9246_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nmeth.4116","volume":"14","author":"M Matsumoto","year":"2017","unstructured":"Matsumoto M, Matsuzaki F, Oshikawa K, et al. A large-scale targeted proteomics assay resource based on an in vitro human proteome. Nat Methods. 2017;14:251\u20138.","journal-title":"Nat Methods"},{"key":"9246_CR18","doi-asserted-by":"publisher","first-page":"683824","DOI":"10.1155\/2013\/683824","volume":"2013","author":"V Somma","year":"2013","unstructured":"Somma V, Ababneh H, Ababneh A, et al. The novel Crohn\u2019s disease marker anti-GP2 antibody is associated with ileocolonic location of disease. Gastroenterol Res Pract. 2013;2013:683824.","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"9246_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/bmc-2016-0007","volume":"7","author":"V Ganesan","year":"2016","unstructured":"Ganesan V, Ascherman DP, Minden JS. Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases. Biomol Concepts. 2016;7(2):133\u201343.","journal-title":"Biomol Concepts"},{"key":"9246_CR20","doi-asserted-by":"publisher","first-page":"219452","DOI":"10.1155\/2013\/219452","volume":"2013","author":"JE Hale","year":"2013","unstructured":"Hale JE. Advantageous uses of mass spectrometry for the quantification of proteins. Int J Proteomics. 2013;2013:219452.","journal-title":"Int J Proteomics"}],"updated-by":[{"DOI":"10.1186\/s12014-019-9250-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000}}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-019-9246-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12014-019-9246-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-019-9246-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T16:11:27Z","timestamp":1694967087000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-019-9246-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9246"],"URL":"https:\/\/doi.org\/10.1186\/s12014-019-9246-0","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12014-019-9250-4","asserted-by":"object"}]},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"26 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of the article [1], an error was noticed under the heading \u201cImmunoprecipitation on protein G magnetic beads\u201d in \u201cMethods\u201d section.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Boards of Mount Sinai Hospital (MSH), University Health Network (UHN) and the University of Thessaly approved all of our protocols, including collection of tissue and serum samples. UHN REB#: 15-9680. MSH REB#: 18-0077-E. Regarding patient serum samples, written informed consent has been obtained by all participants. An\u00a0ethics committee approval has been obtained by the participating hospitals (University College Hospital and King\u2019s College Hospital).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Eleftherios Diamandis declares that he holds a consultant\/advisory role with Abbott Diagnostics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}